Share This Page
Drug Price Trends for NDC 42291-0071
✉ Email this page to a colleague
Average Pharmacy Cost for 42291-0071
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 42291-0071
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| AZATHIOPRINE 50MG TAB | AvKare, LLC | 42291-0071-01 | 100 | 307.70 | 3.07700 | 2023-06-16 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 42291-0071
Introduction
NDC 42291-0071 is a specific drug formulation listed under the National Drug Code (NDC) system maintained by the U.S. Food and Drug Administration (FDA). This code corresponds to a pharmaceutical product whose market dynamics are driven by several factors, including therapeutic indications, patent status, manufacturing costs, regulatory landscape, and competitive environment. To provide a comprehensive outlook, this analysis evaluates current market positioning, competitive landscape, pricing strategies, and future price projections for NDC 42291-0071.
Product Profile and Therapeutic Market Overview
NDC 42291-0071 pertains to [insert drug name and detailed description if available], indicated primarily for [therapeutic use, e.g., oncology, neurology, cardiovascular, etc.]. The drug's clinical efficacy, safety profile, and approval status influence its adoption rate within targeted treatment settings.
The drug operates within a [specify therapeutic category] market, characterized by rapid evolution driven by advancements in [related fields, e.g., personalized medicine, biologics, etc.]. Currently, the market demands [indicate unmet needs or opportunities, e.g., improved efficacy, reduced side effects, simplification of treatment protocols].
Market Size and Penetration
The current market size for drugs in this class spans approximately $X billion worldwide, with the U.S. accounting for a significant share due to high healthcare expenditure and a robust reimbursement infrastructure. The adoption of drugs similar to NDC 42291-0071 depends on factors such as:
-
Patent Status: Patent exclusivity influences pricing and market share. If this product is under patent protection, exclusivity can enable premium pricing.
-
Regulatory Approvals: FDA approvals, including breakthrough or orphan status, can accelerate market penetration. As of latest data, NDC 42291-0071 has [full/conditional] approval for [indication].
-
Competitive Landscape: Existing alternatives include [list key competitors and similar drugs]. Market share hinges on [efficacy, safety, pricing, patient acceptance, insurer preferences].
-
Reimbursement Dynamics: Payer policies significantly influence drug uptake. Favorable formulary positioning and reimbursement coverage are pivotal.
Pricing Dynamics and Factors Influencing Price
The initial list price of NDC 42291-0071 currently stands at approximately $X per unit, with variations depending on [dose, formulation, package size]. Several key factors influence its pricing strategy:
-
Manufacturing and R&D Costs: High development costs, especially for biologics or complex molecules, justify premium prices.
-
Market Positioning: Exclusive rights via patent extension or regulatory exclusivity allow for higher pricing during the patent lifetime.
-
Reimbursement Environment: Insurance coverage and copay structures influence the actual transaction price.
-
Competitive Pricing: The presence of cheaper generic or biosimilar alternatives exerts downward pressure on pricing.
Price Projection Methodology
Projections rely on multiple models, including trend analysis, patent expiration timelines, regulatory developments, and competitive discounting strategies.
Assumptions Made:
- No immediate patent expirations within the next 3-5 years.
- Continued demand driven by [indication] prevalence, estimated at X million patients globally.
- Regulatory or reimbursement changes remain neutral or supportive.
- Competitive pressures only moderately affect pricing due to differentiation and patent protection.
Price Trajectory Outlook (Next 3–5 Years):
| Year | Price per Unit (Est.) | Rationale |
|---|---|---|
| 2023 | $X | Current market, stable demand, no patent challenges |
| 2024-2025 | $X – ($Y) | Anticipated modest price increases driven by inflation and demand |
| 2026-2027 | $X – ($Z) | Possible patent expiry or biosimilar entry, leading to price erosion |
Note: The projections assume no major disruptions—such as regulatory setbacks or significant advancements in competing therapies—occur in this period.
Market Risks and Opportunities
Risks:
- Patent expiration, leading to commoditization by generics or biosimilars.
- Pricing pressures induced by payer negotiations and shifts toward value-based care.
- Regulatory hurdles or safety concerns impacting approval or market retention.
Opportunities:
- Expansion into emerging markets with increasing healthcare access.
- Lifecycle management strategies such as formulation improvements or new indications.
- Strategic alliances for co-marketing or licensing to extend market reach.
Regulatory and Policy Impact
The shifting landscape of healthcare policy, particularly regarding drug pricing transparency and value-based reimbursement models, poses both challenges and opportunities. Policymakers proposing negotiation rights for Medicare or penalties for high drug prices could result in downward pressure. Conversely, incentives for innovation might support sustained premium pricing for novel therapeutics like NDC 42291-0071.
Competitive Landscape
Key competitors include [list of main competitors], with average price points ranging from $A to $B per unit. Biosimilar or generic versions, upon approval, could erode market share and force pricing downward by [percentage] over the next few years.
Market differentiation factors such as superior efficacy, fewer side effects, or novel administration methods can sustain premium pricing and market share.
Conclusion
NDC 42291-0071’s market position and pricing will primarily depend on patent protection status, clinical differentiation, and reimbursement policies. The current pricing reflects a balance of market exclusivity, development costs, and competitive landscape. Projections suggest modest pricing growth over the next few years if patent exclusivity persists, with potential declines following patent expirations or biosimilar entries.
Key Takeaways
- Stable revenue potential in the near term driven by patent protection, high unmet medical needs, and differentiated clinical profile.
- Pricing is susceptible to competitive pressures from biosimilars and generics, especially post-patent expiry.
- Market expansion into emerging regions could offer additional revenue streams but may involve pricing concessions.
- Regulatory developments and healthcare policies will heavily influence pricing and market access strategies.
- Lifecycle strategy and innovation remain essential to sustain pricing power and market relevance.
FAQs
1. What factors most influence the price of NDC 42291-0071?
Patent status, manufacturing costs, competitive landscape, clinical efficacy, and reimbursement policies primarily determine its pricing.
2. When might the drug’s price decrease significantly?
Typically upon patent expiry, which exposes the product to biosimilar and generic competition, leading to substantial price reductions.
3. How does reimbursement impact the drug’s market price?
Positive reimbursement policies enable higher list prices by ensuring coverage and reducing out-of-pocket costs for patients, while restricted reimbursement can compel price discounts.
4. What are key strategies to maintain market share for this drug?
Innovation, securing regulatory exclusivity, expanding indications, optimizing pricing negotiations, and highlighting clinical differentiation.
5. How will regulatory policies affect this drug’s future market?
Stringent pricing transparency and negotiation policies may exert downward pressure, but favorable regulatory approval and expanded indications can bolster market stability.
Sources
- FDA NDC Directory. (2023).
- Market research reports on targeted therapeutic areas, 2022-2023.
- Industry analyses on pharmaceutical patent trends and biosimilar impact.
- Publicly available price and formulary data from healthcare payers.
- Expert insights into healthcare policy and drug pricing strategies (internal analysis).
More… ↓
